- Release Date: 13/10/22 09:47
- Summary: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
- Price Sensitive: Yes
- Download Document 5.36MB
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 33.0¢ | $312.1K | 926.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 211578 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 54719 | 2 |
View Market Depth
| Last trade - 10.19am 07/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |